Unleashing the Power of Channel Engagement for Pharmaceutical Breakthroughs
Channel engagement in the pharmaceutical industry is complex, shaped by a multi-layered supply chain that connects brands, stockists, distributors, retailers (pharmacists/chemists), and consumers. Retailers, especially in the OTC (over the counter) segment, play a critical role but often face prescription dependencies. Meanwhile, pharmaceutical brands grapple with internal challenges, including fragmented data across departments, making it difficult to map diverse patient journeys. Competitive pressures from online retailers offering deep discounts and the need to manage an extensive range of SKUs further complicate brand visibility and inventory control.
A recent BI WORLDWIDE study revealed that two-thirds of channel partners in India’s pharmaceutical sector feel “trapped” in their brand relationships. Many remain with a brand not out of loyalty, but due to a lack of credible alternatives. Surprisingly, not all Indian pharma brands have dedicated loyalty programs to strengthen these partnerships. Strict regulatory constraints often limit how pharma brands can design incentive programs, leading many to focus more on doctor engagement than retailer relationships. However, trust remains a defining factor in the industry, with channel partners valuing reputation and long-standing relationships over short-term performance metrics.
To understand what drives engagement, BI WORLDWIDE India partnered with KANTAR to explore channel partners’ expectations in the Indian pharmaceutical industry. The research found that well-structured loyalty programs, meaningful rewards, and consistent recognition play a key role. Acknowledging channel partners at events, highlighting them in brand communications, and celebrating their milestones help build lasting engagement and satisfaction.
These insights have shaped BI WORLDWIDE India’s proprietary engagement tools, including the Affection Matrix and the IBC Solution Framework—Invest, Build, Consider. By leveraging these solutions, pharmaceutical brands can design targeted chemist warehouse loyalty programs, retail pharmacy loyalty programs, as well as doctor and patient loyalty programs—creating stronger, more meaningful connections across their networks.
Strengthening Loyalty in Pharmaceutical Channel Partner Networks
Given the industry’s strict regulations, BI WORLDWIDE India helps pharmaceutical brands design compliant, results-driven loyalty programs that nurture stronger, healthier partnerships. A seamless omnichannel communication strategy, combined with an engaging rewards and recognition framework, helps brands increase visibility and stay top of mind with their channel partners. By focusing on what truly drives loyalty, pharma brands can build lasting relationships that fuel sustainable growth.